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Abstract. In addition to objective indicators (e.g. laboratory values),
clinical data often contain subjective evaluations by experts (e.g. disease
severity assessments). While objective indicators are more transparent
and robust, the subjective evaluation contains a wealth of expert knowl-
edge and intuition. In this work, we demonstrate the potential of pairwise
ranking methods to align the subjective evaluation with objective indica-
tors, creating a new score that combines their advantages and facilitates
diagnosis. In a case study on patients at risk for developing Psoriatic
Arthritis, we illustrate that the resulting score (1) increases classifica-
tion accuracy when detecting disease presence/absence, (2) is sparse and
(3) provides a nuanced assessment of severity for subsequent analysis.
Keywords: Clinical Data · Ranking SVM · Data Integration.
1 Introduction
In data obtained from clinical studies it is often challenging to determine the
disease status of a patient. There are usually multiple ways for a disease to
manifest and the ways of manifestation are detected by different examination
methods. While the assessment e.g. of swelling of a specific joint is relatively
objective and can be performed by a non-specialist as well, the determination
of which symptoms are directly caused by the disease in question including the
generation of a complete symptomatic picture is no trivial task.
In general, an overall assessment is approximated by a numerical disease ac-
tivity (DA) rating specified by the physician. Although such a rating implicitly
contains valuable domain expertise when provided by an experienced specialist,
the absence of strong diagnostic criteria makes it highly subjective. For exam-
ple, the well-established Visual Analog Scale (VAS) is a standard measurement
instrument for DA assessment of arthritic diseases, but it has been previously
shown that VAS differences of as much as 15% fall within the expected vari-
ance [13].
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In contrast to the DA rating, the variables describing individual symptoms
are more objective; however, it takes domain knowledge to weight them correctly
and assess the resulting score. Our goal is to align the DA rating with symptom
variables to combine the advantages of the two scores within a single rating.
We implement this by learning to predict relative DA rankings from individual
symptoms, using a Ranking SVM [4]. A general challenge is that ratings of the
same disease activity may vary widely although the symptoms remain similar.
Only patients with significantly larger disease activity express more relevant
disease signs leading to substantially different ratings. We address this issue in
our method in order to reduce noise.
To evaluate the resulting model, we test the correlation of the new score to
the original DA rating and also its ability to predict the most reliable binary
examination result (presence or absence of the disease); if our new score captures
the severity of disease more accurately than the raw DA rating, it should also
distinguish better between absence and presence of disease. Furthermore, we
expect a meaningful model to be sparse.
2 Method
We denote the normalized variables of the dataset describing the clinical features
(m symptoms of n patients) as X = {x1, . . . ,xn},xi ∈ R
m and the label (phy-
sicians’ ratings of DA for all patients) as y ∈ Rn. We extend the concept of
the Ranking SVM [4], which learns pairwise rankings of data points based on
pairwise differences. In order to account for inaccuracies in y, we adapt the
method by training only on pairs where y differs by at least δ ∈ R:
xpairedp = xi − xj ,
ypairedp = sign(yi − yj)
}
for p ∈ {(i, j) | i < j and |yi − yj | ≥ δ}.
After training a regular SVM on the set of new data points, we obtain a
weighting vector w and the decision function
i has lower DA than j ⇔ w⊤(xi − xj) < 0⇔ w
⊤xi < w
⊤xj .
Thus, for a set of new patients I and their respective symptoms xi, i ∈ I, we can
calculate w⊤xi for each of them and use this as a new score that maintains an
approximate order according to disease activity, as illustrated by the equation
above. The approximation is that only pairs of patients with sufficiently different
DA are used for training the weights w of the SVM.
3 Related Work
The original Ranking SVM [4] was developed to solve ordinal regression, i. e.,
regression on fixed categories that have an order. There, data points are paired
and an SVM learns to arrange them according to the order of their categories.
Aligning Subjective Ratings in Clinical Decision Making 3
In comparison, our method can also handle a continuous scale without fixed
categories by learning only on clearly distinguishable points.
Another possibility to reflect different levels of confidence regarding the order
of different pairs was introduced by Kotsiantis et al. [7], where the pairs are
weighted according to their label difference. We may evaluate this approach in
future work, although level of confidence and label difference are not necessarily
linearly dependent in our use case.
The Ranking SVM has also been used in Image Recognition to predict the
age of humans based on pictures [1]. This problem exhibits similarities to the
challenge of DA ratings, since large age difference can easily be identified, but
slight differences are hard to detect.
4 Evaluation
We evaluated our method in the context of the skin condition Psoriasis and
the risk of developing Psoriatic Arthritis (PsA): Although psoriasis is closely
related to PsA (as 30% of psoriasis patients will develop PsA over time), a
common problem of PsA is the lack of a clear correlation between disease dura-
tion, phenotype of skin psoriasis and PsA development. Non-expert physicians
frequently misdiagnose PsA due to the multitude of different clinical manifes-
tations and symptoms [11]. If diagnosis is late, patients can develop irreversible
musculoskeletal damage [2].
When PsA first emerged, disease activity scores were often derived from
those developed for Rheumatoid Arthritis (RA), e.g. DAS28 [3]. However, it has
become evident today that despite some similarities, the development and the
type of manifestation of RA and PsA are very different and therefore they cannot
be evaluated by the same scoring systems. This motivates the development of
more accurate assessment scores or tools for PsA.
In a prospective study [6], 391 eligible patients diagnosed with psoriasis vul-
garis and the risk for development of PsA were included. About 35% of them
were diagnosed with PsA during the examinations as part of the study.
The presence of PsA is indicated by a binary examination result (PsA de-
tected in physical examination), a rating of disease activity (DA) of PsA on
a Visual Analog Scale by the physician, and by various symptom assessments
(swollen/tender joints, lab values, etc.). Our goal is to align the subjective dis-
ease activity rating with the more objective symptom assessments. Therefore, we
measure the correlation between the new score and the original disease activity
rating. Additionally, we test the ROC-AUC when using the new score to predict
if the disease is present or not, as indicated by the binary examination result.
We compare the Ranking SVM to two baseline models for mirroring the DA:
simple Linear Regression and Support Vector Regression (SVR). When testing
the ability to predict the presence/absence of disease, we compare the Ranking
SVM to the same two baselines as well as to the original, raw DA rating provided
by the physician. All models are L1-regularized (optimized separately) and linear
in order to obtain a sparse and interpretable solution, especially because of the
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Fig. 1. Left: Similar correlation of all models with DA. Center: Scores from Ranking
SVM and SVR can predict the binary label better than raw DA ratings; Linear Re-
gression performs worse than raw rating. Right: Ranking SVM needs fewer nonzero
coefficients than SVR.
medical context. We calculate the DA predictions (via Linear Regression and
SVR) and the ranking score (via Ranking SVM) for every patient by using 5-
fold cross validation (CV).
In the Ranking SVM, we set δ to 15 (DA ratings range from 0-100), since this
is the minimal clinically important improvement in physician global assessment
(absolute value) as determined in [13].
Stability tests (plots omitted due to space limitations) for δ ranging between
10 and 40 imply that the mean correlation of the new score with DA drops with
higher δ, but only by 0.07 in the tested range. The mean ROC-AUC of detecting
disease presence is stable (variation < 0.03) and the number of coefficients drops
from 31 to 6 when increasing δ from 10 to 40. Accordingly, we conclude that the
choice is not critical and we chose 15 as value for δ due to the semantic reasons
explained above.
Figure 1 shows the results of 100 runs with different CV-splits, since the in-
homogeneity of the limited data set led to high fluctuations in performance. All
models correlate similarly with DA, but the Ranking SVM is the most stable.
With regards to detecting disease presence, both Ranking SVM and SVR en-
hance the raw DA rating. However, the Ranking SVM performs slightly better
and needs 20% fewer nonzero coefficients than the SVR, which is highly rele-
vant since obtaining medical information is costly and time-consuming. A pure
classifier SVM was trained to predict the binary label as well (plots omitted due
to space limitations); although the mean ROC-AUC was 0.04 higher than the
ROC-AUC obtained by using the Ranking SVM, the average correlation with
DA was lower by 0.17.
5 Conclusion and Future Work
We have created a score to reflect disease activity which integrates subjective
expert knowledge with (more) objective symptom descriptions and which is able
to detect the presence of PsA better than the expert rating alone is. It needs fewer
than 25 nonzero coefficients on average – compare this to the well-established
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DAS28 score [3], which needs 58 attributes (assessment of 28 joints for swelling
and tenderness plus lab value plus physician’s rating of DA).
However, this is a work in progress. In future work, we aim to improve the
Ranking SVM in several ways. First, by finding a way to integrate pairs below
the distance threshold. Second, by improving the evaluation methodology, since
the current large number of cross-validations and the limited data set make it
impossible to set aside a data set of similar size for fitting the sparsity parameters.
Third, we aim to extend the method to other use cases. One of them is that
physicians and the patients themselves often rate disease activity differently. For
example, Lebwohl et al. [9] show that for Psoriasis patients itching is the factor
contributing most to high DA according to their opinion, whereas dermatologists
put the highest emphasis on the size and location of skin lesions. The idea is to see
this reflected in the weights of the Ranking SVM. Besides that, the alignment
of disease activity ratings with symptoms has implications for other complex
diseases with an activity rating as well, e.g. multiple sclerosis or schizophrenia.
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